Vericel Corp. (VCEL)
40.15
+0.71
(+1.80%)
USD |
NASDAQ |
Oct 02, 16:00
40.15
0.00 (0.00%)
After-Hours: 20:00
Vericel EPS Diluted (Quarterly) : 0.0422 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0422 |
| March 31, 2026 | -0.1241 |
| December 31, 2025 | 0.4464 |
| September 30, 2025 | 0.0978 |
| June 30, 2025 | -0.011 |
| March 31, 2025 | -0.2254 |
| December 31, 2024 | 0.3794 |
| September 30, 2024 | -0.0184 |
| June 30, 2024 | -0.0962 |
| March 31, 2024 | -0.0802 |
| December 31, 2023 | 0.2572 |
| September 30, 2023 | -0.0768 |
| June 30, 2023 | -0.1055 |
| March 31, 2023 | -0.1582 |
| December 31, 2022 | 0.1204 |
| September 30, 2022 | -0.1394 |
| June 30, 2022 | -0.1902 |
| March 31, 2022 | -0.1509 |
| December 31, 2021 | 0.0908 |
| September 30, 2021 | -0.1057 |
| June 30, 2021 | -0.0816 |
| March 31, 2021 | -0.0715 |
| December 31, 2020 | 0.254 |
| September 30, 2020 | 0.0765 |
| June 30, 2020 | -0.1832 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.1047 |
| December 31, 2019 | 0.203 |
| September 30, 2019 | 0.0744 |
| June 30, 2019 | -0.4503 |
| March 31, 2019 | -0.065 |
| December 31, 2018 | 0.1136 |
| September 30, 2018 | -0.0249 |
| June 30, 2018 | -0.12 |
| March 31, 2018 | -0.2119 |
| December 31, 2017 | 0.01 |
| September 30, 2017 | -0.16 |
| June 30, 2017 | -0.07 |
| March 31, 2017 | -0.31 |
| December 31, 2016 | -0.34 |
| September 30, 2016 | -0.38 |
| June 30, 2016 | -0.22 |
| March 31, 2016 | -0.24 |
| December 31, 2015 | -0.28 |
| September 30, 2015 | -0.26 |
| June 30, 2015 | -0.16 |
| March 31, 2015 | -0.27 |
| December 31, 2014 | -0.17 |
| September 30, 2014 | -0.82 |
| June 30, 2014 | -0.94 |
| March 31, 2014 | -1.26 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AbbVie, Inc. | 2.033 |
| ADMA Biologics, Inc. | 0.1642 |
| Kyntra Bio, Inc. | 2.958 |
| Conexeu Sciences, Inc. | -0.282 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.206M |
| Revenue (Quarterly) | 77.46M |
| Total Expenses (Quarterly) | 75.25M |
| Enterprise Value | 1.987B |
| Gross Profit Margin (Quarterly) | 72.82% |
| Profit Margin (Quarterly) | 2.85% |
| Earnings Yield | 1.15% |
| Operating Earnings Yield | 0.88% |
| Normalized Earnings Yield | 1.151 |